$MNKD News

MannKind Advances Inhaled IPF Drug to Global Phase 2, Eyes FUROSCIX Growth

Cantor Fitzgerald Reiterates Overweight on MannKind, Maintains $8 Price Target

Learn Why The Bull Case For MannKind Stock Could Change Following Outpatient Diuretic Data

Chardan Capital Initiates Coverage On MannKind with Buy Rating, Announces Price Target of $10

Does MannKind (MNKD) Have a Differentiated Cardiorenal Strategy or Just Incremental Delivery Innovation?

MannKind to Participate in the Chardan Healthcare Conference

Reported Friday, MannKind’s Under-10-Second Furoscix ReadyFlow Autoinjector Shows Urine Output Comparable To IV Furosemide In New HFSA 2026 Analyses, Supporting Outpatient Edema Management In Heart Failure And CKD

MannKind Data at HFSA 2026 Highlights New Evidence Supporting Furoscix ReadyFlow™ for the Outpatient Management of Edema in Heart Failure (HF) and Chronic Kidney Disease (CKD)

Truist Securities Maintains Buy on MannKind, Lowers Price Target to $5

MannKind Sees Early ReadyFlow Demand as Pediatric Afrezza Launch Gains Momentum

MannKind (MNKD) Bets On Inhaled Weight Loss Amid Widening Losses

Cantor Fitzgerald Reiterates Overweight on MannKind, Maintains $8 Price Target

MannKind Expands Into Weight Loss With Rose Pharma Deal – Here’s What Investors Are Watching

Breathing In GLP-1: MannKind Partners With Rose Pharma for Inhaled Weight Management Molecule

MannKind and Rose Pharma Inc Enter Licensing and Collaboration Agreement to Develop an Inhaled Rapid-Acting, Short-Duration GLP-1 for Weight Management

MannKind And Rose Pharma Enter Into Worldwide Licensing And Collaboration Agreement To Develop ROSE-010 Technosphere For Weight Management

MannKind (MNKD) Could Be 48% Undervalued Following Its Afrezza And Pipeline Narrative

MannKind Files Prospectus For Resale By Selling Stockholders Of Up to 12,853,470 Shares, Including 2,412,632 Shares Underlying Pre-Funded Warrants

MannKind: New Approvals Majorly Increase MannKind's Prospects

MannKind Corporation 2026 Q2 - Results - Earnings Call Presentation